Oct 22, 2026 04:11PM
Oct 5, 2026 05:00PM
Sep 17, 2026 04:07PM
Sep 17, 2026 04:07PM
Aug 6, 2026 04:05PM
Aug 5, 2026 05:00PM
Jul 23, 2026 04:10PM Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
Jul 2, 2026 05:03PM
Jun 3, 2026 05:00PM
May 7, 2026 04:05PM
May 6, 2026 05:15PM
Apr 23, 2026 04:15PM
Apr 2, 2026 05:15PM
Feb 26, 2026 04:05PM Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 23, 2026 04:15PM
Feb 12, 2026 04:07PM
Feb 4, 2026 05:05PM
Jan 22, 2026 05:00AM
Jan 7, 2026 05:15PM
Dec 22, 2025 04:10PM
Dec 2, 2025 05:15PM Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 05:05PM
Nov 6, 2025 04:05PM
Oct 23, 2025 04:10PM
Oct 2, 2025 05:21PM
Sep 4, 2025 05:25PM
Sep 2, 2025 04:07PM
Aug 8, 2025 05:00PM Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Aug 7, 2025 04:05PM
Jul 24, 2025 04:15PM
Jul 2, 2025 05:03PM
Jun 4, 2025 05:33PM
May 8, 2025 04:05PM
May 6, 2025 05:15PM
Apr 30, 2025 06:00AM Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients
Apr 28, 2025 03:03PM
Apr 24, 2025 04:11PM
Apr 2, 2025 05:15PM
Mar 26, 2025 09:00AM
Mar 5, 2025 06:06PM
Mar 5, 2025 06:05PM
Mar 5, 2025 05:30PM Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
Mar 5, 2025 04:11PM
Feb 27, 2025 04:05PM
Feb 26, 2025 04:15PM
Feb 13, 2025 04:15PM
Feb 5, 2025 05:05PM
Jan 3, 2025 05:15PM
Dec 23, 2024 09:01AM Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
Dec 4, 2024 05:15PM

335,386 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All